Paul Cowan

Paul founded Quotient in 2007 following the acquisition of Alba Bioscience. He has broad healthcare industry experience gained over 15 years working in industry and in investment banking. Prior to founding Quotient, Paul was the CFO of Inveresk Research Group, a major pre-clinical contract research organisation acquired by Charles River Laboratories in 2004. Prior to that he was a senior executive with Bear Stearns (heading up its European biotechnology practice) and Deutsche Morgan Grenfell.